Whitehawk Therapeutics, Inc. WHWK
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 7.15M | 14.38M | 21.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 7.15M | 14.38M | 21.60M |
| Cost of Revenue | -57.60M | -57.60M | -56.84M | -20.79M | -24.33M |
| Gross Profit | 57.60M | 57.60M | 63.98M | 35.17M | 45.93M |
| SG&A Expenses | 22.57M | 23.30M | 29.82M | 35.01M | 36.99M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 86.06M | 122.70M | 121.55M | 122.85M | 121.29M |
| Operating Income | -86.06M | -122.70M | -114.40M | -108.46M | -99.69M |
| Income Before Tax | -79.83M | -115.81M | -20.60M | -15.62M | -10.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -79.83 | -115.81 | -20.60 | -15.62 | -10.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -79.83M | -115.81M | -20.60M | -15.62M | -10.42M |
| EBIT | -86.06M | -122.70M | -114.40M | -108.46M | -99.69M |
| EBITDA | -86.06M | -122.68M | -114.32M | -108.34M | -99.52M |
| EPS Basic | -1.11 | -1.67 | 0.49 | 0.15 | -0.06 |
| Normalized Basic EPS | -0.69 | -1.05 | -1.07 | -1.28 | -1.35 |
| EPS Diluted | -1.12 | -1.68 | 0.47 | 0.13 | -0.07 |
| Normalized Diluted EPS | -0.69 | -1.05 | -1.07 | -1.28 | -1.35 |
| Average Basic Shares Outstanding | 290.54M | 276.74M | 247.14M | 205.02M | 162.85M |
| Average Diluted Shares Outstanding | 290.54M | 276.74M | 247.43M | 205.31M | 163.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |